Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

Vijay Kedia-backed cybersecurity stock announces 1:1 bonus issue. Check details

Shares of Vijay Kedia-backed TAC Infosec rose on news of a one-for-one bonus issue, backed by strong financial performance, including a 157%...